Pericentriolar material analyses in normal esophageal mucosa, Barrett's metaplasia and adenocarcinoma

Histology and Histopathology

Volumn 25, Issue 5, 2010, Pages 551-560

  Segat, Daniela ^a   Cassaro, Mauro ^a   Dazzo, Emanuela ^a   Cavallini, Lucia ^a   Romualdi, Chiara ^a   Salvador, Renato ^a   Vitale, Maria Pia ^a   Vitiello, Libero ^a   Fassan, Matteo ^a   Rugge, Massimo ^a   Zaninotto, Giovanni ^a,b   Ancona, Ermanno ^a,c   Baroni, Maurizio David ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b SS Giovanni e Paolo Hospital   (Italy)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Barrett's metaplasia; Centrosome; Esophageal adenocarcinoma; Immunohistochemistry; Pericentriolar proteins

Indexed keywords

ANTIGEN; PERICENTRIN; TUBULIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BIOLOGICAL MODEL; CENTROSOME; CHROMOSOMAL INSTABILITY; ESOPHAGUS; ESOPHAGUS TUMOR; FEMALE; GENETICS; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; METAPLASIA; MIDDLE AGED; MUCOSA; PATHOLOGY; PRECANCER; PROGNOSIS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS; BARRETT ESOPHAGUS; CENTROSOME; CHROMOSOMAL INSTABILITY; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; METAPLASIA; MIDDLE AGED; MODELS, BIOLOGICAL; MUCOUS MEMBRANE; PRECANCEROUS CONDITIONS; PROGNOSIS; TUBULIN;

EID: 77953052483     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Atherfold P.A. and Jankowski J.A. (2006). Molecular biology of Barrett's cancer. Best. Pract. Res. Clin. Gastroenterol. 20, 813-827.
2. Barrett M.T., Sanchez C.A., Prevo L.J., Wong D.J., Galipeau P.C., Paulson T.G., Rabinovitch P.S. and Reid B.J. (1999). Evolution of neoplastic cell lineage in Barrett's oesophagus. Nat. Genet. 22, 106-109.
3. Basto R., Brunk K., Vinadogrova T., Peel N., Franz A., Khodjakov A. and Raff J.W. (2008). Centrosome amplification can initiate tumorigenesis in flies. Cell 133, 1032-1042.
4. Benjamini Y. and Hochberg Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. Roy. Stat. Soc. B. 57, 289-300.
5. Boveri T. (1914). Zur Frage der Entstehung maligner Tumoren. (English Translation: The Origin of Malignant Tumors. Williams and Wilkins. Baltimore, Maryland, 1929).
6. Chae S., Yun C., Um H., Lee J.H. and Cho H. (2005). Centrosome amplification and multinuclear phenotypes are Induced by hydrogen peroxide. Exp. Mol. Med. 37, 482-487.
7. Chaves P., Crespo M., Ribeiro C., Laranjeira C., Pereira A.D., Suspiro A., Cardoso P., Leitão C.N. and Soares J. (2007). Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved. Mod. Pathol. 20, 788-796.
8. Chen Y. and Kong Q. (2009). Evaluation of centrosome abnormalities and p53 inactivation in chemical induced hepatocellular carcinogenesis. Neoplasma 56, 169-176.
9. Chng W.J., Ahmann G.J., Henderson K., Santana-Davila R., Greipp P.R., Gertz M.A., Lacy M.Q., Dispenzieri A., Kumar S., Rajkumar S.V., Lust J.A., Kyle R.A., Zeldenrust S.R., Hayman S.R. and Fonseca R. (2006). Clinical implication of centrosome amplification in plasma cell neoplasm. Blood 107, 3669-3675.
10. Coad R.A., Woodman A.C., Warner P.J., Barr H., Wright N.A. and Shepherd N.A. (2005). On the histogenesis of Barrett's oesophagus and its associated squamous islands: a three-dimensional study of their morphological relationship with native oesophageal gland ducts. J. Pathol. 206, 388-394.
11. D'Assoro A.B., Barrett S.L., Folk C., Negron V.C., Boeneman K., Busby R., Whitehead C., Stivala F., Lingle W.L. and Salisbury J.L. (2002). Amplified centrosomes in breast cancer: a potential indicator of tumor aggressiveness. Breast Cancer Res. Treat. 75, 25-34.
12. Duensing S. (2005). A tentative classification of centrosome abnormalities in cancer. Cell. Biol. Int. 29, 352-359.
13. Fukasawa K. (2005). Centrosome amplification, chromosome instability and cancer development. Cancer Lett. 230, 6-19.
14. Galipeau P.C., Cowan D.S., Sanchez C.A., Barrett M.T., Emond M.J., Levine D.S., Rabinovitch P.S. and Reid B.J. (1996). 17p (p53) allelic losses, 4N (G2/tetraploid) populations and progression to aneuploidy in Barrett's oesophagus. Proc. Natl. Acad. Sci. USA 93, 7081-7084.
15. Garewal H.S., Sampliner R., Liu Y. and Trent J.M. (1989). Chromosomal rearrangements in Barrett's oesophagus. A premalignant lesion of esophageal adenocarcinoma. Cancer Genet. Cytogenet. 15, 281-286.
16. Genta R.M. (2006). Assessing the regression of Barrett esophagus: don't try it at home. Adv. Anat. Pathol. 13, 127-130.
17. Giehl M., Fabarius A., Frank O., Hochhaus A., Hafner M., Hehlmann R. and Seifarth W. (2005). Centrosome aberrations in chronic myeloid leukemia correlate with stage of disease and chromosomal instability. Leukemia 19, 192-197.
18. Goepfert T.M., Adigun Y.E., Zhong L., Gay J., Medina D. and Brinkley W.R. (2002). Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis. Cancer Res. 62, 4115-4122.
19. Gustafson L.M., Gleich L.L., Fukasawa K., Chadwell J., Miller M.A., Stambrook P.J. and Gluckman J.L. (2000). Centrosome hyperamplification in head and neck squamous cell carcinoma: a potential phenotypic marker of tumor aggressiveness. Laryngoscope 110, 1798-1801.
20. Kahrilas PJ. (2008). Clinical practice. Gastroesophageal reflux disease. N. Engl. J. Med. 359, 1700-1707.
21. Lai L.A., Paulson T.G., Li X., Sanchez C.A., Maley C., Odze R.D., Reid B.J. and Rabinovitch P.S. (2007). Increasing genomic instability during premalignant neoplastic progression revealed through high resolution array-CGH. Genes Chromosomes Cancer 46, 532-542.
22. Lengauer C., Kinzler K.W. and Vogelstein B. (1998). Genetic instabilities in human cancers. Nature 396, 643-649.
23. Lingle W.L., Barrett S.L., Negron V.C., D'Assoro A.B., Boeneman K., Liu W., Whitehead C.M., Reynolds C. and Salisbury J.L. (2002). Centrosome amplification drives chromosomal instability in breast tumor development. Proc. Natl. Acad. Sci. USA 99, 1978-1983.
24. Lothschütz D., Jennewein M., Pahl S., Lausberg H.F., Eichler A., Mutschler W., Hanselmann R.G. and Oberringer M. (2002). Polyploidization and centrosome hyperamplification in inflammatory bronchi. Inflamm. Res. 51, 416-422.
25. Merlo L.M., Pepper J.W., Reid B.J. and Maley C.C. (2006). Cancer as an evolutionary and ecological process. Nat. Rev. Cancer 6, 924-935.
26. Milliken E.L., Lozada K.L., Johnson E., Landis M.D., Seachrist D.D., Whitten I., Sutton A.L., Abdul-Karim F.W. and Keri R.A. (2008). Ovarian hyperstimulation induces centrosome amplification and aneuploid mammary tumors independently of alterations in p53 in a transgenic mouse model of breast cancer. Oncogene 27,1759-1766.
27. Nigg E.A. (2002). Centrosome aberrations: cause or consequence of cancer progression? Nat. Rev. Cancer 2, 815-825.
28. Nigg E.A. (2006). Origins and consequences of centrosome aberrations in human cancers. Int. J. Cancer 119, 2717-2723.
29. Oberg S., Wenner J., Johansson J., Walther B. and Willen R. (2005). Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma. Ann. Surg. 242, 49-54.
30. Pihan G.A., Purohit A, Wallace J., Malhotra R., Liotta L. and Doxsey S.J. (2001). Centrosome defects can account for cellular and genetic changes that characterize prostate cancer progression. Cancer Res. 61, 2212-2219.
31. Pihan G.A., Wallace J., Zhou Y. and Doxsey S.J. (2003). Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. Cancer Res. 63, 1398-13404.
32. Salisbury J.L. (2001). The contribution of epigenetic changes to abnormal centrosomes and genomic instability in breast cancer. J. Mammary Gland Biol. Neoplasia 6, 203-212.
33. Schatten H. (2008). The mammalian centrosome and its functional significance. Histochem. Cell Biol. 129, 667-686.
34. Seery J.P. and Watt F.M. (2000). Asymmetric stem-cell divisions define the architecture of human oesophageal epithelium. Curr Biol. 10, 1447-1450.
35. Shaheen N.J. and Richter J.E. (2009). Barrett's oesophagus. Lancet 373, 850-61.
36. Souza R.F., Krishnan K. and Spechler S.J. (2008). Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G211-218.
37. Spechler S.J. (2002). Clinical practice. Barrett's esophagus. N. Engl. J. Med. 346, 836-842.
38. Storchova Z. and Kuffer C. (2008). The consequences of tetraploidy and aneuploidy. J. Cell Sci. 121, 3859-3866.
39. Teodori L., Göhde W., Persiani M., Ferrario F., Tirindelli Danesi D., Scarpignato C., Di Tondo U., Alò P. and Capurso L. (1998). DNA/protein flow cytometry as a predictive marker of malignancy in dysplasia-free Barrett's esophagus: thirteen-year follow-up study on a cohort of patients. Cytometry 34, 257-263.
40. Tischoff I. and Tannapfel A. (2008). Barrett's esophagus: can biomarkers predict progression to malignancy. Expert Rev. Gastroenterol. Hepatol. 5, 653-663.
41. Wang K.K. and Sampliner R.E. (2008). Practice Parameters Committee of the American College of Gastroenterology Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus. Am. J. Gastroenterol. 103, 788-797.
42. Wani S., Puli S.R., Shaheen N.J., Westhoff B., Slehria S., Bansal A., Rastogi A., Sayana H. and Sharma P. (2009). Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review. Am. J. Gastroenterol. 104, 502-513.
43. Wild C.P. and Hardie L.J. (2003). Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat. Rev. Cancer 3, 676-684.
44. Yamamoto Y., Matsuyama H., Furuya T., Oga A., Yoshihiro S., Okuda M., Kawauchi S., Sasaki K. and Naito K. (2004). Centrosome hyperamplification predicts progression and tumor recurrence in bladder cancer. Clin. Cancer Res. 10, 6449-6455.